Cure Rate of Helicobacter Pylori Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cure Rate of Helicobacter Pylori Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT07344506

CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Erad…

This study, titled CURE-H. Pylori, is a three-arm, parallel-group, open-label, randomized controlled trial designed to evaluate the effectiveness of Dexlansopra…

Pakistan942 participantsStarted 2025-05-01

Treatment: Arm 1: Dexlansoprazole + Levofloxacin-Based Triple Therapy, Arm 2: Lansoprazole + Levofloxacin-Based Triple Therapy

All recent trials (2 shown)

CompletedPhase 4

NCT01742429

Levoﬂoxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter P…

To test the efﬁcacy of 14 day levoﬂoxacin and bismuth-containing second-line therapy for resistant Helicobacter pylori infection, to compare with the classical…

China200 participantsStarted 2012-11

Treatment: Proton pump inhibitor, Bismuth subsalicylate